TechnicalBuy's Once a Year Investment OpportunityIt’s here. That once a year investment opportunity when the confluence of company achieving significant milestones, pending news, and buildup in investor interest all come together. I’ve been researching, calling, investigating and waiting for that perfect opportunity. The wait is over. I found 2 perfect investments that will reward anyone savvy enough to get in front of the crowd and watch their money grow.
For those that recall, the last time I found such a perfect opportunity was back on December 23/11, in a post entitled Bioasis Excitement I wrote:
“I think Bioasis is now in the telegraphing stage where all signs are pointing to an exciting 2012 and majority of investors are not understanding this. For any investors looking for that once a season breakthrough investment, take a look at Bioasis.”
Bioasis was trading at $0.60 at the time. Only six weeks later, the stock had reached a high of $1.83, and by October of 2012 it reached $2.13.
We are now in the same position with two biotech companies entering what is known as the sweet spot for biotech deal-making. That is the completion of Phase II clinical trials when all biotechs expect to bag a lucrative deal. This with a good reason as the valuation of biotechs is highest around phase II trials (see this EP Vantage analysis for a comprehensive breakdown).
I’ve followed both stories for a while and I’ve done a lot of research, including meeting with the CEOs, and getting input from investment bankers and other industry insiders. I’ve owned both stocks, but I feel now is the time to back up the truck and load up as the investor interest is about to push the stock price higher in a matter of weeks.
The first company is Diamedica...
TB